STI Testing to Enhance PrEP Use in Pregnancy
Recruiting · NCT06919614 · Interventional (participants receive a specific treatment) · Lead sponsor: Botswana Harvard AIDS Institute Partnership
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The investigators are conducting a study in Botswana to see if offering STI testing along with expanded HIV prevention options (PrEP) helps more pregnant women start and continue using PrEP during and after pregnancy. Pregnant women (n=600) seeking antenatal care in Botswana will be enrolled and randomly assigned to receive the standard of care (standard STI assessment with no STI testing) versus STI testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis during pregnancy and postpartum. The investigators' hypothesis is that providing STI testing alongside PrEP offer will encourage more women to start and continue using PrEP.
Who can take part
Inclusion criteria
- Pregnant and seeking antenatal care
- Self-identifying as a cis-gender woman
- Living without HIV
- Not currently using PrEP
- Planning to remain in the city/town of enrolment until 9 months post-delivery.
- Planning to receive antenatal and postnatal care in the city/town of enrolment.
- Willing and able to provide informed consent
Exclusion criteria
- Male gender
- Not pregnant
- Living with HIV
- Currently using PrEP
- Not planning to remain in the city/town of enrolment until 9 months post-delivery
- Not planning to receive antenatal and postnatal care in the city/town to enrolment
- Not able or willing to provide informed consent for participation
Where it is running
1 location listed.
- DHMT Clinics - Gaborone, Botswana